Main > ONCOLOGY (**) > Lung>NSCLC>MET>PD-L1>1% > TREAT.: > USA. B. PD-1 MAb+CTLA-4 MAb Inj.

---

USA. B. PD-1 MAb+CTLA-4 MAb Inj.'s subsections
(*) USA Approval Date: 2020. 05.15.
Company
CTLA: Cytotoxic T-Lymphocyte
Generic Names>
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2020. 09.15.
RTM

USA. B. PD-1 MAb+CTLA-4 MAb Inj.'s products
This section has no products